Earlier this week BIO signed of a Memorandum of Understanding for Cooperation with the Pharmaceutical Association Committee (RDPAC). RDPAC is a non-profit organization located within the China Association of Enterprises with Foreign Investment (CAEFI) and has a membership of 38 multi-national companies with pharmaceutical R&D capabilities in China.
This agreement continues the longstanding relationship between BIO and RDPAC and deepens our cooperative efforts to advance advocacy and outreach for the biotechnology industry in China. Together we will continue to highlight the value of this industry in benefiting society and addressing global health challenges.
Mike Dethick, Managing Directorat RDPAC and Joe Damond, Executive Vice President, International Affairs of BIO exchange signed MOU documents
Powered by WPeMatico